Edition:
United Kingdom

People: Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

3,757JPY
19 Sep 2019
Change (% chg)

¥15 (+0.40%)
Prev Close
¥3,742
Open
¥3,743
Day's High
¥3,776
Day's Low
¥3,739
Volume
4,720,400
Avg. Vol
5,175,948
52-wk High
¥4,943
52-wk Low
¥3,401

Weber, Christophe 

Mr. Christophe Weber has been serving as President, Chief Executive Officer and Representative Director in Takeda Pharmaceutical Company Limited since April 1, 2015. He used to work for GlaxoSmithKline K.K.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --